A - Human Necessities – 61 – F
Patent
A - Human Necessities
61
F
A61F 2/06 (2006.01) A61F 2/00 (2006.01) A61F 2/02 (2006.01)
Patent
CA 2445524
Restenosis of arteries after angioplasty in inhibited by implanting in the treated artery a stent (100) having the struts (102) coated with a composition including a statin (106) having anti-restenotic activity. Such statins may also be incorporated in a collagen or polymer matrix (106) that forms a coating covering the struts (102) and interstices (104) of the stent (100).
Selon cette invention, on inhibe la resténose des artères après angioplastie en implantant dans l'artère traitée un stent (100) dont les entretoises (102) sont recouvertes d'une composition comprenant une statine (106) à activité antiresténotique. Ces statines peuvent être également incorporées dans une matrice de collagène ou polymère (106) qui forme un revêtement recouvrant les entretoises (102) et les interstices (104) du stent (100).
Epstein Stephen E.
Fuchs Shmuel
Stabile Eugenio
Mbm Intellectual Property Law Llp
The Medstar Research Institute
LandOfFree
Stent-based delivery of statins to prevent restenosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stent-based delivery of statins to prevent restenosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stent-based delivery of statins to prevent restenosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2025543